AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$PACS

Conway Patrick Hugh sold $155K of PACS

Conway Patrick Hugh sold 3,497 shares of PACS Group, Inc. (PACS) at $44.41 ($0.16M total) on 2026-08-14.

Original reporting
SEC EDGAR · Conway Patrick Hugh
Published Aug 27, 2026, 10:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 11:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$PACS
Bearish
medium confidence
Mentioned
$PACS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which may be viewed negatively by the market.

02

Market read

Small insider sale with limited material impact; may cause short-term price pressure.

03

What to watch

No indication of upcoming corporate actions or earnings that might explain the sale.

Relevance 4/10Novelty 4/10Timing: filing date 2026-08-27

Background

Form 4 filings disclose insider transactions; director sales are monitored for potential signals.

Company-level read

Ticker impact

$PACSBearishMedium confidence
Context

Director Conway Patrick Hugh sold 3,497 shares for $155,301, reducing his stake to 8,947 shares.

Expected impact

Possible modest dip in PACS share price over the next few days.

Evidence & confidence

The sale size is modest relative to market cap, but director sales often attract trader attention.

Market effects

Sector

Minimal impact on the broader healthcare services sector.

Regional

Limited to investors tracking PACS; no regional effect.

Global

Low global relevance.

Counterpoint

What could challenge this read

The sale could be unrelated to confidence and merely portfolio rebalancing.

Key entities

  • Director
    Conway Patrick Hugh

    Insider who sold shares.

  • Company
    PACS Group, Inc.

    Issuer of the shares sold.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

PACS insider trading history →

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

finance.yahoo.com
$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

finance.yahoo.com
$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.

investing.com